Shuttle Pharmaceuticals Holdings (SHPH) Equity Ratio (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Equity Ratio history runs 6 years deep, the most recent figure standing at 0.28 for Q1 2026.

• In Q1 2026, Equity Ratio fell 54.2% year-over-year to 0.28; the TTM figure through Mar 2026 stood at 0.28 (down 54.2% YoY), while the FY2025 annual figure was 0.22, down 23.94% from the prior year.
• Equity Ratio was 0.28 for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from 0.22 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.9 in Q3 2022 to a low of 1.95 in Q3 2024.
• Historically, Equity Ratio has averaged 0.4 across 5 years, with a median of 0.62 in 2025.
• The sharpest annual moves came in 2022 and 2024: Equity Ratio jumped 132.77% in 2022, then tumbled 356.76% in 2024.
• A 5-year view of Equity Ratio shows it stood at 0.89 in 2022, then retreated by 23.2% to 0.68 in 2023, then slumped by 58.48% to 0.28 in 2024, then fell by 23.94% to 0.22 in 2025, then soared by 31.67% to 0.28 in 2026.
• The last three Equity Ratio figures came in at 0.28 (Q1 2026), 0.22 (Q4 2025), and 0.39 (Q3 2025), per Business Quant data.